Abstract CT034: Activation of the antitumor immune response of gamma9delta2 T cells in patients with solid or hematologic malignancies with ICT01, a first-in-class, monoclonal antibody targeting butyrophilin 3A: The EVICTION study
Year: 2021
Type: conference-abstract
Source: Cancer Research
Institutions: Institut Gustave Roussy, Université Libre de Bruxelles, Institut Jules Bordet, Institute of Cancer Research, Institut Paoli-Calmettes, Technische Universität Dresden, Vall d'Hebron Institute of Oncology, Centre Hospitalier Universitaire de Nantes, Yale Cancer Center, Centre National de la Recherche Scientifique, Inserm, Aix-Marseille Université, Centre de Recherche en Cancérologie de Marseille
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3182143239
